|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-12-17
|
|
pubmed:abstractText |
To evaluate the individual and combined diagnostic utility of MOC-31, HBME-1 and MOC-31mRNA in the differentiation of adenocarcinoma cells from reactive mesothelial cells in pleural effusions.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0001-5547
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
619-24
|
|
pubmed:meshHeading |
pubmed-meshheading:20014549-Antibodies, Monoclonal,
pubmed-meshheading:20014549-Epithelium,
pubmed-meshheading:20014549-Female,
pubmed-meshheading:20014549-Gene Expression Regulation,
pubmed-meshheading:20014549-Humans,
pubmed-meshheading:20014549-Male,
pubmed-meshheading:20014549-Neoplasms,
pubmed-meshheading:20014549-Pleural Effusion,
pubmed-meshheading:20014549-RNA, Messenger,
pubmed-meshheading:20014549-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20014549-Sensitivity and Specificity,
pubmed-meshheading:20014549-Tumor Markers, Biological
|
|
pubmed:articleTitle |
Diagnostic utility of MOC-31, HBME-1 and MOC-31 mRNA in distinguishing between carcinoma cells and reactive mesothelial cells in pleural effusions.
|
|
pubmed:affiliation |
Department of Pathology, First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
